NASDAQ: BTAI - BioXcel

Yield per half year: +49.25%
Sector: Healthcare

BioXcel

Underestimation
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 48.77 -100% -7.66 -100%
P/S 63.96 33.76 89.46%
P/BV -1.56 4.82 -132.4%
P/FCF -0.8173 60.98 -101.34%
Ev/Ebitda -0.7495 -22.12 -96.61%
Ev/S 90.16 22.56 299.6%
Ev/FCF -0.8026 68.75 -101.17%
E/P -1.41 0.0178 -8033.08%
Efficiency
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-12030.07 4.83 -249150.93% -84328325.27 -99.99%
ROE 316.86 9.61 3198.54%
ROA -242.94 0.3359 -72424.47%
ROIC -58.4 7.63 -864.96%
ROS -12974.86 -25.17 51448.67%
ROCE 294.35 15.33 1819.96%
Debt
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.608 -3.67 -83.41% -0.3678 65.33%
Nеt Debt/Ebitda -0.2178 -3.44 -93.67%
Debt/Ratio 1.37 0.1972 594.71%
Debt/Equity 91.77 1.65 5473.67%
Debt/Net Income -0.5638 10.31 -105.47%
Dividends
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5496 -100% 0 0%
Number of years of dividend growth 0 0.1053 -100%
DSI 0 0.2174 -100%
Average dividend growth 0 0.0654 -100%
Average percentage for 5 years 0 0.4928 -100%
Average percentage for payments 0 43.56 -100%
Difference from average difference in sector -0.5496
Growth impulse
Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue 5 years
10/10
268 -56.89 -571.08%
Growth impulse Ebitda 5 years 396.38 -64.81 -711.6%
Growth impulse Net Income 5 years 442.58 -58.33 -858.75%
Growth impulse FCF 5 years 453.66 -47 -1065.23%
Growth impulse EPS 5 years 204.3 -32.41 -730.36%
IP Score
4.74/10

Similar companies

Amgen

Alexion

ABIOMED

Gilead Sciences